184 related articles for article (PubMed ID: 37343509)
21. Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.
Seino Y; Kuwata H; Yabe D
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):102-9. PubMed ID: 27186364
[TBL] [Abstract][Full Text] [Related]
22. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes.
Zhuo M; D'Andrea E; Paik JM; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Patorno E
JAMA Netw Open; 2022 Oct; 5(10):e2235995. PubMed ID: 36219443
[TBL] [Abstract][Full Text] [Related]
23. Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review.
Ruan Z; Zou H; Lei Q; Ung COL; Shi H; Hu H
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):555-574. PubMed ID: 35152812
[TBL] [Abstract][Full Text] [Related]
24. Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.
Yang W; Cai X; Gao X; Chen Y; Chen L; Ji L
J Diabetes Investig; 2018 Jul; 9(4):813-821. PubMed ID: 29047219
[TBL] [Abstract][Full Text] [Related]
25. Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.
D'Andrea E; Wexler DJ; Kim SC; Paik JM; Alt E; Patorno E
JAMA Intern Med; 2023 Mar; 183(3):242-254. PubMed ID: 36745425
[TBL] [Abstract][Full Text] [Related]
26. Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Yokoyama H; Haneda M
Front Endocrinol (Lausanne); 2020; 11():214. PubMed ID: 32390941
[No Abstract] [Full Text] [Related]
27. Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i.
Lanzinger S; Schmid SM; Welp R; Zimmermann A; Fasching P; Wagner S; Holl RW
Diabetes Res Clin Pract; 2018 Dec; 146():162-171. PubMed ID: 30367902
[TBL] [Abstract][Full Text] [Related]
28. Case Report: Appearance of Various Disease-Specific Antibodies After the Onset of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.
Iwamoto Y; Anno T; Koyama K; Kawasaki F; Kaku K; Tomoda K; Sugiyama S; Aoyama Y; Kaneto H
Front Immunol; 2022; 13():843480. PubMed ID: 35309321
[TBL] [Abstract][Full Text] [Related]
29. Clinical features of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in Japan: A nationwide retrospective observational study.
Sugiyama S; Yamamoto T; Aoyama Y
J Dermatol; 2022 Jul; 49(7):697-702. PubMed ID: 35478414
[TBL] [Abstract][Full Text] [Related]
30. Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients.
Li PF; Chung CH; Liu JS; Lu CH; Su SC; Kuo FC; Ho LJ; Chen KC; Su YT; Chu NF; Lee CH; Hsieh CH; Hung YJ; Lin FH; Chien WC; Liang YJ
Ther Adv Respir Dis; 2022; 16():17534666221135320. PubMed ID: 36448591
[TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl Peptidase (DPP)-4 Inhibitor Impairs the Outcomes of Patients with Type 2 Diabetes Mellitus After Curative Resection for Colorectal Cancer.
Saito A; Kitayama J; Horie H; Koinuma K; Kawashima R; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N
Cancer Res Commun; 2021 Nov; 1(2):106-114. PubMed ID: 36860286
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with the discontinuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) after initiation of insulin.
Fernandes G; Matos JE; Jaffe DH; Beyer G; Yang L; Iglay K; Gantz I; Rajpathak S
Curr Med Res Opin; 2020 Mar; 36(3):377-386. PubMed ID: 31771370
[No Abstract] [Full Text] [Related]
33. Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis.
Ferrannini G; Lund LH; Benson L; Rizzo M; Almahmeed W; Rosano GMC; Savarese G; Cosentino F
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):10-17. PubMed ID: 35963647
[TBL] [Abstract][Full Text] [Related]
34. Clinical effectiveness of switching between DPP-4 inhibitors in patients with type 2 diabetes mellitus
.
Suzuki Y; Tanaka A; Tanaka M; Hidaka N; Miyake T; Matsuura B; Hiasa Y; Araki H
Int J Clin Pharmacol Ther; 2019 Sep; 57(9):474-477. PubMed ID: 31232277
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.
McCoy RG; Van Houten HK; Deng Y; Mandic PK; Ross JS; Montori VM; Shah ND
JAMA Netw Open; 2021 Feb; 4(2):e2035792. PubMed ID: 33523188
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials.
Tran S; Retnakaran R; Zinman B; Kramer CK
Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():68-76. PubMed ID: 29364587
[TBL] [Abstract][Full Text] [Related]
37. Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP-4i) in US Adults with Type 2 Diabetes.
Tan X; Liang Y; Gamble C; King A
Diabetes Ther; 2024 Feb; 15(2):427-445. PubMed ID: 38060149
[TBL] [Abstract][Full Text] [Related]
38. Should Baseline Hemoglobin A
Uhrig JL; Page SO; Mishriky BM; Patil SP; Powell JR; Sewell K; Mian MR; Cummings DM
J Clin Pharmacol; 2020 Aug; 60(8):980-991. PubMed ID: 32396236
[TBL] [Abstract][Full Text] [Related]
39. Predictors of efficacy of GLP-1 agonists and DPP-4 inhibitors: A systematic review.
Bihan H; Ng WL; Magliano DJ; Shaw JE
Diabetes Res Clin Pract; 2016 Nov; 121():27-34. PubMed ID: 27622682
[TBL] [Abstract][Full Text] [Related]
40. Outcomes Associated With the Adjunctive Use of Dipeptidyl Peptidase-4 Inhibitors With Insulin Versus Other Antihyperglycemic Medications in Patients With Prediabetes or Diabetes After Cardiac Surgery.
Clark L; Weeda E; Griffin ML; Jones LA; Haney J
J Pharm Pract; 2021 Apr; 34(2):259-264. PubMed ID: 31409190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
